Article Text

Download PDFPDF
Significance of systemic to pulmonary artery collaterals in single ventricle physiology: new insights from CMR imaging
  1. Ashwin Prakash
  1. Department of Cardiology, Children's Hospital Boston and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA
  1. Correspondence to Dr Ashwin Prakash, Department of Cardiology, Children's Hospital Boston, 300 Longwood Avenue, Boston, MA 02115, USA; ashwin.prakash{at}cardio.chboston.org

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Introduction

Systemic to pulmonary artery collaterals (SPCs) are ubiquitous in single ventricle physiology, being found in nearly two-thirds of patients after a bidirectional Glenn operation and in approximately half of patients after a Fontan operation.1 They arise most commonly from the subclavian artery or one of its branches and supply systemic arterial blood to the distal pulmonary vasculature. The risk factors and pathogenic mechanisms that lead to the formation of SPCs remain poorly characterized, but chronic hypoxaemia, diminished pulmonary blood flow, surgical scarring, branch pulmonary artery stenosis, inflammation and abnormal flow patterns in the pulmonary arteries have all been hypothesised to contribute to their formation, although these hypotheses remain largely untested.

In theory, SPCs may have beneficial effects in single ventricle physiology. By providing additional pulmonary blood flow, SPCs may promote pulmonary artery growth and improve systemic oxygen saturation. They may also prevent the formation of pulmonary arteriovenous malformations by supplying ‘hepatic factor’. However, more attention is usually focused on the potential harmful consequences of SPC flow including ventricular dilation, recirculation of oxygenated blood to the lungs resulting in ineffective pulmonary blood flow, energy losses related to competing sources of pulmonary blood flow and, rarely, erosion into a bronchus resulting in life-threatening haemoptysis. These physiological abnormalities have been hypothesised to contribute to adverse clinical outcomes. Excessive SPC flow is thought to contribute to increased pleural drainage after a Fontan operation, which can prolong recovery in the postoperative period. In the longer term, persistent SPC flow has been implicated in the pathogenesis of ventricular dysfunction, heart failure and protein-losing enteropathy. However, most of these hypotheses have not been tested and the few data that exist are contradictory. For example, two similar studies that sought to investigate if increased SPC flow was associated …

View Full Text

Footnotes

  • Linked article 301599.

  • Competing interests None.

  • Ethics approval This is an editorial for which ethics approval was not required.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles